Minerva Surgical (UTRS)

Minerva Surgical Stock Analysis & Ratings

UTRS Stock Chart & Stats

Day’s Range$2.5 - $2.5
52-Week Range$1.61 - $10.37
Previous Close$2.5
Average Volume (3M)36.15K
Market Cap$72.09M
P/E RatioN/A
Next EarningsMay 11, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score8
EPS (TTM)0.00



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Minerva Surgical’s price range in the past 12 months?
Minerva Surgical lowest stock price was $1.60 and its highest was $10.37 in the past 12 months.
    What is Minerva Surgical’s market cap?
    Minerva Surgical’s market cap is $72.09M.
      What is Minerva Surgical’s price target?
      The average price target for Minerva Surgical is $10.67. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $14.00 ,the lowest forecast is $6.00. The average price target represents 326.80% Increase from the current price of $2.5.
        What do analysts say about Minerva Surgical?
        Minerva Surgical’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
          When is Minerva Surgical’s upcoming earnings report date?
          Minerva Surgical’s upcoming earnings report date is May 11, 2022 which is 15 days ago.
            How were Minerva Surgical’s earnings last quarter?
            Minerva Surgical released its earnings results on Mar 08, 2022. The company reported $0.1 earnings per share for the quarter, beating the consensus estimate of -$0.296 by $0.396.
              Is Minerva Surgical overvalued?
              According to Wall Street analysts Minerva Surgical’s price is currently Undervalued.
                Does Minerva Surgical pay dividends?
                Minerva Surgical does not currently pay dividends.
                What is Minerva Surgical’s EPS estimate?
                Minerva Surgical’s EPS estimate is -$0.38.
                  How many shares outstanding does Minerva Surgical have?
                  Minerva Surgical has 28,830,000 shares outstanding.
                    What happened to Minerva Surgical’s price movement after its last earnings report?
                    Minerva Surgical reported an EPS of $0.1 in its last earnings report, beating expectations of -$0.296. Following the earnings report the stock price went down -12.06%.
                      Which hedge fund is a major shareholder of Minerva Surgical?
                      Among the largest hedge funds holding Minerva Surgical’s share is Versant Venture Management, LLC. It holds Minerva Surgical’s shares valued at 8M.


                        Minerva Surgical Stock Analysis

                        Smart Score
                        Price Target
                        ▲(326.80% Upside)
                        Strong Buy
                        The Minerva Surgical stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                        Learn more about TipRanks Smart Score

                        Company Description

                        Minerva Surgical

                        Minerva Surgical Inc is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women.

                        Popular Stocks

                        What's Included in PREMIUM?
                        Make informed decisions based on Top Analysts' activity
                        Know what industry insiders are buying
                        Get actionable alerts from top Wall Street Analysts
                        Find out before anyone else which stock is going to shoot up
                        Get powerful stock screeners & detailed portfolio analysis